Skip to content
Govbase
Govbase
Congress·In Committee·S. 4323

Ensuring Access to Lower-Cost Medicines for Seniors Act

Sen. Lankford and Sen. Hassan Introduce Bill to Force Medicare Plans to Cover Cheaper Generic Drugs

This bill is currently in the early stages of the legislative process after being sent to the Senate Committee on Finance for review. It is considered active, but no further hearings or votes have been scheduled at this time. There is no companion bill currently associated with this legislation.

Legislative Progress

Senate
House
President
Law
Could go either way

The bill has support from both parties, which helps it move forward. However, it still needs to pass through committees where many bills get stuck.

Key Points

Healthcare

Impact Analysis

Personal Impact

Life & Work

Generic drug manufacturers and smaller pharmaceutical companies that produce biosimilars could see increased market access. By requiring formulary inclusion when their products cost less than the brand-name version, these companies gain guaranteed shelf space in Medicare drug plans that currently may exclude them in favor of brand-name drugs with larger rebates.

the formulary shall include each part D generic drug of such part D reference drug for which the wholesale acquisition cost is less than the wholesale acquisition cost of such part D reference drug.
2
2
2
5
+2
ImpactCertaintyScopeDurationSentiment

Programs

Disabilities

Milestones

2 milestones2 actions
Apr 16, 2026Senate

Read twice and referred to the Committee on Finance.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Apr 16, 2026

Introduced in Senate

The bill was officially filed and given a number. It now enters the legislative queue.

Votes

No votes have been recorded for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

Ensuring Access to Lower-Cost Medicines for Seniors Act

Bill NumberS 4323
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Finance.

Sponsor

Cosponsors

(1)
D: 1

Analysis generated by AI. Always verify with official sources.